HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

6- ethyl- N,N'- bis(3- hydroxyphenyl)(1,3,5)triazine- 2,4- diamine

structure in first source

Also Known As:

RS-0466

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Triazines: 306
    - 6-ethyl-N,N'-bis(3-hydroxyphenyl)(1,3,5)triazine-2,4-diamine: 2

Experts

1.	Kaneko, Isao: 2 articles (12/2003 - 12/2002)
2.	Kogen, Hiroshi: 2 articles (12/2003 - 12/2002)
3.	Koyama, Kazuo: 2 articles (12/2003 - 12/2002)
4.	Kubo, Takekazu: 2 articles (12/2003 - 12/2002)
5.	Marumoto, Shinji: 2 articles (12/2003 - 12/2002)
6.	Meguro, Masaki: 2 articles (12/2003 - 12/2002)
7.	Murasugi, Takako: 2 articles (12/2003 - 12/2002)
8.	Nakagami, Yasuhiro: 2 articles (12/2003 - 12/2002)
9.	Nishimura, Satoko: 2 articles (12/2003 - 12/2002)
10.	Oda, Tomiichiro: 2 articles (12/2003 - 12/2002)

Related Diseases

1.

Alzheimer Disease (Alzheimer's Disease)

12/13/2002 - "These results raise the possibility that RS-0466 or its derivatives have potential as a therapeutic agent for Alzheimer's disease patients, and its effect is at least in part mediated by activation of Akt."
12/01/2003 - "These results raise the possibility that RS-0466 or one of its derivatives has potential to enhance the neuroprotective effect of brain-derived neurotrophic factor, and could serve as a therapeutic agent for patients with Alzheimer's disease."

Related Drugs and Biologics

1.	Brain-Derived Neurotrophic Factor (BDNF)
2.	Neuroprotective Agents